EI
PRCT icon

EAM Investors’s Procept Biorobotics PRCT Stock Holding History

EAM Investors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-57,547
Closed -$4.63M – 332
2024
Q4 		$4.63M Sell
57,547
-1,217
-2% -$104K 0.66% 51
2024
Q3 		$4.71M Buy
58,764
+104
+0.2% +$7.39K 0.7% 38
2024
Q2 		$3.58M Buy
+58,660
New +$3.49M 0.58% 85
2022
Q4 		– Sell
-49,430
Closed -$2.05M – 323
2022
Q3 		$2.05M Sell
49,430
-7,914
-14% -$316K 0.45% 86
2022
Q2 		$1.88M Buy
+57,344
New +$2.09M 0.46% 77

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM Investors's PRCT Position: Q1 2025 in Review

EAM Investors sold out of Procept Biorobotics (PRCT) in Q1 2025, closing a stake of 57,547 shares — an estimated $4.63M sold.

EAM Investors first reported a position in PRCT in Q2 2022 and held it in 5 quarters. The position peaked at $4.71M in Q3 2024. 279 funds tracked by Wall St. Rank hold PRCT as of Q1 2025.

  • EAM Investors reported no remaining Procept Biorobotics position as of Q1 2025 after selling out during the quarter.
  • EAM Investors sold 57,547 Procept Biorobotics shares in Q1 2025, an estimated $4.63M.
  • EAM Investors first reported a position in Procept Biorobotics in Q2 2022 and held it in 5 quarters.
  • EAM Investors's Procept Biorobotics position peaked at $4.71M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2025.

Based on EAM Investors's 13F filing for Q1 2025, filed 13 May 2025.